Acid Reflux (GERD): Why Your Symptoms and Treatment History Matter to Research

Every figure in this guide comes from a published source, linked where it appears and kept in CureCircle's evidence base with the source's own words. It is not medical advice. Read on 7 November 2026.

Acid reflux is so common that it is easy to forget how much it shapes a life: what you eat and when, how you sleep, years of tablets that work, stop working, or bring worries of their own. Most of it is managed with the person's own judgement, between short appointments. Which foods, habits and medicines actually made a difference, and for whom, is what research on reflux needs, and people living with it hold the answers.

How many people live with it

The Global Burden of Disease study counted 825.60 million people with gastroesophageal reflux disease in 2021, up from 450.76 million in 1990, and 324.1 million new cases in 2021.

The records worth keeping

NICE's guideline on reflux and dyspepsia describes the treatment and tests that leave records:

• A course of acid-reducing tablets: a full-dose PPI for 4 or 8 weeks. Your prescription history shows every course, step-up and step-down.
• An H. pylori test, offered as 'test and treat' to people with dyspepsia.
• An endoscopy in some cases, which NICE says to consider if the person has GORD to look for Barrett's oesophagus. Its report and any biopsy results are worth keeping.
• A yearly review for long-term treatment, with encouragement to try stepping down or stopping treatment.

A symptom diary, what you ate, when symptoms came and what helped, shows the pattern no test does. If you do not have your endoscopy report, ask your practice or hospital for a copy.

What sharing it is worth

CureCircle values every contribution with a public benchmark built from what health data has sold for. A complete reflux story with the records the guideline lists comes to about $93 per licence on the benchmark today. With 60 days of symptom diary entries added, it comes to about $277 per licence, because day-by-day records linked to treatment are evidence research rarely gets. Every line and its source is on the acid reflux page.

A licence is not a one-off sale: the same de-identified story can be licensed to several research teams, and you earn a share each time.

How to share it

You start by writing what you live with in your own words; a few quick questions follow, then an AI interviewer asks about the details only you know, and you rate every treatment you tried, from antacids and PPIs to diet changes and surgery. You can add endoscopy reports, prescriptions and pages of a symptom diary as PDFs or photos, and the AI reads them into your own medical file. Before anything is shared, you read the de-identified summary and decide.

Start your story, or read what your health data is worth first.